Position in RPRX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$598,547
-$2,276,887 QoQ
Shares Held
10,675
-85.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#378
of 641 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qsemble Capital Management, LP holds $7,848,553 across 6 Biotechnology names. RPRX ranks #4 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
31,633 | $2,356,025 | |
| 2 | INSM |
INSMED Inc
|
21,148 | $2,254,799 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
47,971 | $1,871,348 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
10,675 | $598,547 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
5,639 | $459,634 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
3,887 | $308,200 |
All Filings in RPRX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $598,547 | 10,675 | Shares | Sole | 2026-08-03 | |
| 2025-12-31 | $2,875,434 | 74,416 | Shares | Sole | 2026-02-05 | |
| 2025-06-30 | $2,628,532 | 72,954 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $364,189 | 11,699 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $4,592,310 | 180,020 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,117,256 | 39,493 | Shares | Sole | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||